Page 7,056«..1020..7,0557,0567,0577,058..7,0707,080..»

Inaugural ETSU pharmacy school class dons white coats

Posted: Published on March 3rd, 2012

Inaugural ETSU pharmacy school class dons white coats Published January 8th, 2007 10:57 pm The ETSU College of Pharmacy's inaugural class of 72 put on white coats for Monday's ceremony. Photo by Tony Duncan. JOHNSON CITY - Being the first East Tennessee State University pharmacy student to don a white coat may have been the luck of the alphabet, but Sarah Adams was proud to be first in line Monday. "It's just a very big honor," Adams said after the ceremony recognizing the new ETSU College of Pharmacy's official opening at the D.P. Culp University Center. "Words can't describe it. They really can't. It's just unbelievable." The former high school biology teacher was one of 72 students to put on the coats symbolizing their status as members of the school's inaugural class. A Kingsport native, Adams set out to make the career change after Gov. Phil Bredesen pledged his support for ETSU's pharmacy school proposal on March 17, 2005. "When the governor came to make the announcement a couple of years ago, that's when I saw it on the news, and I was really excited about it," Adams said. "I think it's a wonderful opportunity for everybody in this area … Continue reading →

Posted in Pharmacy | Comments Off on Inaugural ETSU pharmacy school class dons white coats

Pat was Diagnosed with “CMT” Disease and was Given a Second Chance with a Stem Cell Treatment

Posted: Published on March 3rd, 2012

Pat receive a life altering Stem Cell Treatment with the help of World Stem Cells, LLC. Pat went from couch bound to walking 1.5 miles on country dirt road, climbing stairs, gardening and playing piano all thanks to a stem cell treatment. (PRWEB) March 03, 2012 Pats neurological disorder is hereditary, and the official position of the National Institute of Neurological Disorders and Stroke is that CMT has no cure. Decades ago, Pat had gone to a neurologist for electromyography, or EMG. The purpose of the procedure was to evaluate her muscle function, and it involved painful needles and days of muscle soreness after each session. Pats neurologist had refused to tell her the results because he said that she would just give up if she knew how bad they were. At this point, Pats symptoms were so crippling and unbearable that she contacted World Stem Cells, LLC worldstemcells.com to explore stem cell treatment as an option. She knew that the procedures were still being developed and experimental, and that they came with no guarantees. She remained interested in learning more and becoming educated on the options presented. At the time, she was unable to walk without a four-leg quad … Continue reading →

Comments Off on Pat was Diagnosed with “CMT” Disease and was Given a Second Chance with a Stem Cell Treatment

NJ CVS mixed up cancer meds with kids' fluoride

Posted: Published on March 3rd, 2012

TRENTON, N.J. (AP) -- A CVS pharmacy in northeastern New Jersey mistakenly distributed pills for the treatment of breast cancer to children instead of the fluoride pills that were prescribed, company and state officials said Friday. CVS Caremark said in a statement that it is "deeply sorry for the mistake that occurred" at its Chatham, N.J. pharmacy. The company did not explain how the mistake happened. There has been no report of injury. New Jersey Attorney General Jeffrey S. Chiesa said in an administrative order Friday that the pharmacy acknowledged that it improperly dispensed the breast cancer fighting drug Tamoxifen instead chewable fluoride tablets to children in as many as 50 families between Dec. 1, 2011 and Feb. 20. Fluoride helps prevent tooth decay and is usually prescribed by dentists for children. Tamoxifen is used to treat breast cancer in men and women and blocks the female hormone estrogen. Mike DeAngelis, CVS's director of public relations, said in a statement that the company had contacted or left messages for every family whose child was dispensed a 0.5 mg fluoride prescription in the previous 60 days. He says that "most of the families we have spoken to did not indicate that … Continue reading →

Posted in Pharmacy | Comments Off on NJ CVS mixed up cancer meds with kids' fluoride

Portsmouth pharmacy worker charged in drug theft

Posted: Published on March 3rd, 2012

Stolen medicine valued at $670 PORTSMOUTH A local pharmacy student used his position as a drug store employee to steal prescription drugs, police allege. Facing two criminal charges, one of them a felony, is James Henschke, 23, of 851 Ocean Blvd., Rye. Henschke allegedly was in possession of a bottle of alprazolam (Xanax) without a prescription and he's also charged with a misdemeanor alleging he stole the pills from a Lafayette Road drug store. According to an affidavit by detective Robert Munson, Henschke was working at the drug store when a co-worker reportedly saw him steal a bottle containing 100 2mg tablets of the prescription drug. When confronted, Henschke put a confession in writing and also admitted to stealing Suboxone and clonazepam during a two-year period, the detective's affidavit states. The pharmacy estimated the value of the stolen drugs at $670.96, according to police. In his report to the Portsmouth court, Munson said he gave Henschke a ride to a Portsmouth home at which he was staying at the time of the alleged Jan. 14 theft, and Henschke led him to a duffle bag containing a stolen bottle of alprazolam with half the pills missing. Henschke admitted he'd taken four … Continue reading →

Posted in Pharmacy | Comments Off on Portsmouth pharmacy worker charged in drug theft

Advanced Cell Technology Announces 2011 Financial Results

Posted: Published on March 3rd, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT, OTCBB: ACTC), a leader in the field of regenerative medicine, today announced year-end results for the year ended December 31, 2011. The Company utilized $13.6 million in cash for operations during the year, compared to $8.8 million in the year-earlier period. The increase in cash utilization resulted primarily from ACTs ongoing clinical activities in the US and Europe. ACT ended the year with cash and cash equivalents of $13.1 million, compared to $15.9 million in cash and cash equivalents in the year-earlier period. Some of the 2011 highlights included: 2011 was a very important and successful year for ACT as we began our Phase 1/2 trials for the treatment of macular degeneration, said Gary Rabin, chairman and CEO of ACT. We are very excited about the preliminary Phase 1/2 clinical data from our dry-AMD and Stargardts disease trials, which were published in The Lancet earlier this year. The data demonstrated the safety of ACTs human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) cells for the treatment of both diseases. The vision of both patients appears to have improved after transplantation, and no adverse safety issues have been observed. We look forward … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Advanced Cell Technology Announces 2011 Financial Results

Cell and signaling pathway that regulates the placental blood stem cell niche identified

Posted: Published on March 3rd, 2012

ScienceDaily (Mar. 1, 2012) UCLA stem cell researchers have discovered a critical placental niche cell and signaling pathway that prevent blood precursors from premature differentiation in the placenta, a process necessary for ensuring proper blood supply for an individual's lifetime. The placental niche, a stem cell "safe zone," supports blood stem cell generation and expansion without promoting differentiation into mature blood cells, allowing the establishment of a pool of precursor cells that provide blood cells for later fetal and post-natal life, said study senior author Dr. Hanna Mikkola, an associate professor of molecular cell and developmental biology and a researcher at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. Mikkola and her team found that PDGF-B signaling in trophoblasts, specialized cells of the placenta that facilitate embryo implantation and gas and nutrient exchanges between mother and fetus, is vital to maintaining the unique microenvironment needed for the blood precursors. When PDGF-B signaling is halted, the blood precursors differentiate prematurely, creating red blood cells in the placenta, Mikkola said. The study, done in mouse models, appears March 1, 2012, in the peer-reviewed journal Developmental Cell. "We had previously discovered that the placenta provides a … Continue reading →

Comments Off on Cell and signaling pathway that regulates the placental blood stem cell niche identified

Stem cell study ‘should aim at innovation in treatment’

Posted: Published on March 3rd, 2012

By Bonnie James Deputy News Editor The stem cell and regenerative therapy programme, constituting a major part of research at Qatar Cardiovascular Research Centre (QCRC), has important clinical and scientific implications, co-chairman Prof Sir Magdi Yacoub has said. He was giving a keynote presentation at the Qatar International Conference on Stem Cell Science and Policy 2012, which concluded on Thursday at Qatar National Convention Centre. Myocardium (the muscular tissue of the heart) regeneration and tissue engineering and valves tissue engineering are among the focal areas at QCRC, which aims to establish in Qatar an internationally competitive centre of excellence for cardio-vascular research. QCRC, which has a heart muscle lab and a tissue engineering, regeneration lab, works with a mission to maintain a translational focus, relevant to the development of health policy and practice, and provide opportunities for capacity building, professional development and research collaborations in Qatar. It is also meant to provide opportunities for biotechnology development in Qatar and contribute to cardio-vascular health in the developing world through improved knowledge base, capacity building and development of appropriate tools and strategies focused on poorer countries. Cardio-vascular diseases (CVDs) kill 17mn people per year globally and there is particularly high incidence in … Continue reading →

Comments Off on Stem cell study ‘should aim at innovation in treatment’

Sickle Cell Blood Test Might Predict Severity of Disease

Posted: Published on March 3rd, 2012

FRIDAY, March 2 (HealthDay News) -- Researchers report they have developed a blood test that can predict which sickle cell patients are most likely to experience the most severe symptoms of the disease. When the blood illness is at its worst, patients can suffer intense pain, internal organ damage and shortened lives. While about 13 million people worldwide are thought to have the disease, which is caused by a genetic mutation, it's not well understood. "We still don't have effective enough therapies, and we don't have a good feel for how the disease manifests itself differently in different people," Sangeeta Bhatia, a professor of health sciences and technology and electrical engineering and computer science at Massachusetts Institute of Technology in Boston, said in a news release from the institute. "When a patient has high cholesterol, you can monitor their risk for heart disease and response to therapy with a blood test. With sickle cell disease, despite patients having the same underlying genetic change, some suffer tremendously while others don't, and we still don't have a test that can guide physicians in making therapeutic decisions." Bhatia and colleagues developed a test that measures the flow of samples of blood to determine … Continue reading →

Posted in Cell Medicine | Comments Off on Sickle Cell Blood Test Might Predict Severity of Disease

The Lipitor warnings: A guide to the FDA's new cholesterol drug labels

Posted: Published on March 3rd, 2012

A class of cholesterol-reducing drugs called statins will now carry labeling noting potential side effects, which include memory loss and higher blood sugar levels The Food and Drug Administration this week officially linked statin drugs a widely prescribed type of cholesterol-reducing medication to risks of memory loss and Type 2 diabetes. Reports of potential side effects have been discussed for years, but this marks the first time health officials have highlighted the potential side effects, and called for warning labels on packaging. Here's what you should know about the FDA's new statin warnings: What are statin drugs? They're a class of medication used to lower patients' cholesterol and fight heart disease. The drugs work by inhibiting a chemical in the liver required to make cholesterol. Popular brands used in the United States include Lipitor (atorvastatin), Crestor (resuvastatin), Zocor (simvastatin), and Vytorin (simvastatin/ezetimibe). SEE ALSO: The web's growing Pinterest 'obsession': By the numbers Do a lot of people use them? Statins are among "the most widely prescribed drugs in the world," says Gardiner Harris at the New York Times. Last year, close to 21 million Americans were prescribed some variation of the drug. Debate of whether statin is over- or under-used … Continue reading →

Posted in Drug Side Effects | Comments Off on The Lipitor warnings: A guide to the FDA's new cholesterol drug labels

Drug-addicted Philly ex-cop gets probation for theft

Posted: Published on March 3rd, 2012

A former Philadelphia police officer who stole a debit card from a prisoner was sentenced by a federal judge to three years probation today. Charles Jacoby III, 31, worked as a patrol officer and cell block attendant in the 22nd police district. Jacoby, of Burholme in the far Northeast, was supposed to safeguard personal items taken from those he recently arrested or prisoners he guarded. Instead, prosecutors said the 10-year veteran stole their debit and credit cards and used them to buy things for himself. At a sentencing today, U.S. District Judge Joel H. Slomsky ordered Jacoby to serve the first nine months of his three year probation under house arrest with electronic monitoring and fined him $1,000. Assistant U.S. Attorney Kevin Brenner said Jacoby targeted individuals who appeared to be under the influence of alcohol or drugs when he was patrolling the streets. When he was working the cell block, Brenner said Jacoby targeted inmates who he thought were acting "rowdy." Brenner likened the ex-cop to a "pickpocket" whose behavior was "startling and stunning." The prosecutor asked Slomsky to draw a "bright line" to send a message to other cops who might be considering criminal misdeeds. Seeking a sentence … Continue reading →

Posted in Drug Dependency | Comments Off on Drug-addicted Philly ex-cop gets probation for theft

Page 7,056«..1020..7,0557,0567,0577,058..7,0707,080..»